Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hengliang Shi, T. Yang, Khalissa Deffar, Chunlan Dong, Jing-ying Liu, Chunyan Fu, Daxue Zheng, Bo Qin, Jun-Jie Wang, Xingzhi Wang, Xiao-Juan Zhu (2011)
A novel single‐chain variable fragment antibody against FGF‐1 inhibits the growth of breast carcinoma cells by blocking the intracrine pathway of FGF‐1IUBMB Life, 63
Zongyi Hu, R. Evarts, K. Fujio, N. Omori, M. Omori, E. Marsden, Snorri Thorgeirsson (1996)
CANCER BIOLOGY: Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c- met and acidic fibroblast growth factor/fibroblast growth factor receptors during hepatocarcinogenesisCarcinogenesis, 17
Li Yan, K. Hsu, R. Beckman (2008)
Antibody-Based Therapy for Solid TumorsThe Cancer Journal, 14
Y. Yamanaka, H. Friess, M. Büchler, H. Beger, E. Uchida, M. Onda, M. Kobrin, M. Korc (1993)
Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.Cancer research, 53 21
M. Mohammadi, S. Froum, J. Hamby, M. Schroeder, R. Panek, G. Lu, A. Eliseenkova, D. Green, J. Schlessinger, S. Hubbard (1998)
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domainThe EMBO Journal, 17
M. Zakrzewska, E. Marcinkowska, A. Wiedlocha (2008)
FGF-1: from biology through engineering to potential medical applications.Critical reviews in clinical laboratory sciences, 45 1
J. Uhm, A. Porter (2017)
Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular EraMayo Clinic Proceedings, 92
M. Koziczak, Thomas Holbro, N. Hynes (2004)
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclinsOncogene, 23
Jing Qing, Xiangnan Du, Yongmei Chen, Pamela Chan, Hao Li, Ping Wu, S. Marsters, S. Stawicki, Janet Tien, K. Totpal, S. Ross, Susanna Stinson, D. Dornan, D. French, Qian-Rena Wang, J. Stephan, Yan Wu, C. Wiesmann, A. Ashkenazi (2009)
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.The Journal of clinical investigation, 119 5
Haijun Sun, Maria Malabunga, J. Tonra, R. Direnzo, F. Carrick, Huiyuan Zheng, H. Berthoud, O. McGuinness, Juqun Shen, P. Bőhlen, R. Leibel, P. Kussie (2007)
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys.American journal of physiology. Endocrinology and metabolism, 292 3
Saori Koshida, K. Asanuma, Kageaki Kuribayashi, M. Goto, N. Tsuji, D. Kobayashi, Maki Tanaka, N. Watanabe (2010)
Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations.Clinica chimica acta; international journal of clinical chemistry, 411 5-6
M. Boyiadzis, K. Foon (2008)
Approved monoclonal antibodies for cancer therapy.Expert opinion on biological therapy, 8 8
N. Cheung, Hong-fen Guo, Jian Hu, D. Tassev, I. Cheung (2012)
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoOncoimmunology, 1
J. Martínez-Torrecuadrada, Gabriela Cifuentes, Paula Lopez-Serra, Pilar Sáenz, Antonio Martínez, J. Casal (2005)
Targeting the Extracellular Domain of Fibroblast Growth Factor Receptor 3 with Human Single-Chain Fv Antibodies Inhibits Bladder Carcinoma Cell Line ProliferationClinical Cancer Research, 11
(2018)
Humanization of fibroblast growth factor 1 single-chain antibody and validation for its antitumorigenic efficacy in breast cancer and glioma cells
C. Hierro, J. Rodón, J. Tabernero (2015)
Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.Seminars in oncology, 42 6
Hengliang Shi, Chunling Fu, Wei Wang, Y. Li, Shuang Du, R. Cao, Jingying Chen, Dong-Sheng Sun, Zhongyu Zhang, Xingzhi Wang, Xiaojuan Zhu (2014)
The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasisJournal of Cellular and Molecular Medicine, 18
N. Chow, K. Cheng, P. Lin, S. Chan, W. Su, Yung-Nien Sun, Xi-Zhang Lin (1998)
Expression of Fibroblast Growth Factor-1 and Fibroblast Growth Factor-2 in Normal Liver and Hepatocellular CarcinomaDigestive Diseases and Sciences, 43
Journal of Cellular and Molecular Medicine – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.